| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 08/17/2006 | WO2006084338A1 Novel tubulin polymerisation inhibitors |
| 08/17/2006 | WO2006037982A3 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases |
| 08/17/2006 | WO2006028977A3 Chiral spiro compounds and their use in asymmetric catalytic reactions |
| 08/17/2006 | WO2005094323A3 Process for preparing a dipeptidyl peptidase iv inhibitor and intermediates employed therein |
| 08/17/2006 | WO2005089813A3 Receptor-avid exogenous optical contrast and therapeutic agents |
| 08/17/2006 | WO2005065046A3 An efficient industrial process for 3-hydroxy-3-(3’-sulfamyl-4’-chlorophenyl)phtalimidine |
| 08/17/2006 | US20060183920 more especially its tert-butylamine salt; synthesis intermediates; carried out in the presence of an activation reagent selected from N-methyl-N-phenyl-aminotriphenylphosphonium iodide and hexamethylphosphorus triamide together with ammonium perchlorate by Mitsunobu reaction |
| 08/17/2006 | US20060183919 Racemizing (2R)-indoline-2-carboxylic acid with a sodium hydroxide solution then reacting product with a chiral amine ((R)- alpha -methylbenzylamine); for inhibiting angiotensin I converting enzyme (or kininase II) |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | CA2597680A1 Process for preparing 2,3-disubstituted indoles |
| 08/17/2006 | CA2597447A1 Novel tubulin polymerisation inhibitors |
| 08/16/2006 | EP1690854A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 08/16/2006 | EP1690853A1 W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/16/2006 | EP1689711A1 Method for producing n- 1-(s)-carbalkoxy-3-phenylpropyl|-s-alanyl-2s, 3ar, 7as-octahydroindol-2-carboxylic acid compounds |
| 08/16/2006 | EP1689710A1 Indole derivatives for use as chemical uncoupler |
| 08/16/2006 | EP1689709A1 N-sulfonyldicarboximide containing tethering compounds |
| 08/16/2006 | EP1689699A2 Anthranilic acid derivatives and their use as activators of the hm74a receptor |
| 08/16/2006 | EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689389A2 Indole compounds |
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0861236B2 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 08/16/2006 | CN1819993A Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same |
| 08/16/2006 | CN1817861A Benzyloxy-substituted tryptophan derivative, its analogs, production and use thereof |
| 08/16/2006 | CN1817860A Asymmetric duplex indole phenylethylene salt compound and high-density recording medium therefor |
| 08/16/2006 | CN1269807C Aryl substituted piperazine for curing benign prostatauxe |
| 08/15/2006 | US7091382 Synthesis of N-methyl-N-phenylaminoacrolein |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091348 Measurement of dye emission |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091234 Thio-oxindole derivatives |
| 08/15/2006 | US7091229 1,1-Dioxo-2H-naphtho(1,8-cd)isothiazole or 2-oxo-2H-benzo(cd)indole derivatives as anticarcinogenic or antiproliferative agents |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7090929 Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions |
| 08/10/2006 | WO2006083538A1 Aminoalkylphenyl indolone derivatives |
| 08/10/2006 | WO2006083536A1 Aminoalkoxyphenyl indolone derivatives |
| 08/10/2006 | WO2006083266A1 Inhibitors of bacterial type iii protein secretion systems |
| 08/10/2006 | WO2006082454A1 Process for the preparation of racemic and optically active 4-chloro-3-[5-chloro-1-(2,4-dimethoxybenzyl)-3-alkyl-2-oxo-2,3-dihydro-1h-indol-3-yl]benzoic acid derivatives using a phase transfer catalyst |
| 08/10/2006 | WO2006082453A1 Racemic and optically active 4-chloro-3-(5-chloro-3-alkyl-2-oxo-2,3-dihydro-1h-indol-3-yl)benzoic acid derivatives and the preparation thereof |
| 08/10/2006 | WO2006082409A2 Tricyclic cytoprotective compounds |
| 08/10/2006 | WO2006082400A1 Indan-amide derivatives with glycogen phosphorylase inhibitory activity |
| 08/10/2006 | WO2006082354A1 Azacyclic compounds as inhibitors of sensory neurone specific channels ( sns ) |
| 08/10/2006 | WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | WO2006045120A3 Purification of tegaserod maleate |
| 08/10/2006 | WO2006044415A3 Carboxylic acid peri - substituted bicyclics for occlusive artery disease |
| 08/10/2006 | WO2006018850A3 Compositions for treating amyloid associated diseases |
| 08/10/2006 | WO2006012310A3 Carbazole derivatives for treating polycystic kidney disease |
| 08/10/2006 | WO2005079496A3 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
| 08/10/2006 | US20060178519 Process for preparing tegaserod |
| 08/10/2006 | US20060178422 Process for making (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl] amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid |
| 08/10/2006 | US20060178421 Hydrogenation catalysts |
| 08/10/2006 | US20060178420 Indole derivatives as anti-inflammatory agents |
| 08/10/2006 | US20060178418 For therapy of asthma, bronchial asthma, chronic obstructive pulmonary disease, allergic rhinitis, eosinophilic granuloma, nephritis, rheumatoid arthritis, cystic fibrosis, chronic bronchitis, multiple sclerosis, Crohns disease, psoraisis, uticaria, adult vernal conjunctivitis, |
| 08/10/2006 | US20060178412 [3-(Benzo[b]thiophene-2-carbonyl)-5-(4-methyl phenyl)-1H-indol-1-yl]-acetic acid, for treating conditions resulting from fibrinolytic disorders, such as deep vein thrombosis, coronary heart disease, and pulmonary fibrosis; Alzheimer's disease |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060177691 Compound and organic light-emitting diode and display utilizing the same |
| 08/10/2006 | US20060177621 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 08/10/2006 | US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
| 08/10/2006 | CA2596736A1 Tricyclic cytoprotective compounds |
| 08/10/2006 | CA2596636A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/09/2006 | EP1688417A2 Phthalocyanine compounds and use thereof in inks for ink jet printing, methods for generating patterns |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1687311A1 Novel compounds |
| 08/09/2006 | EP1687288A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 08/09/2006 | EP1687272A1 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 08/09/2006 | EP1687271A1 A method for the preparation of (2s, 3ar, 7as)-octahydro-1h-indole-2-carboxylic acid as key intermediate in the preparation of trandolapril by reacting a cyclohexyl aziridine with a dialkyl malonate |
| 08/09/2006 | EP1687270A1 Method for preparing (s)-indoline-2-carboxylic acid and (s)-indoline-2-carboxylic acid methyl ester using hydrolytic enzyme |
| 08/09/2006 | EP1686988A1 Indirubin-type compounds, compositions, and methods for their use |
| 08/09/2006 | EP1686987A2 Advanced indolinone based protein kinase inhibitors |
| 08/09/2006 | EP1686986A1 Carvedilol salts, corresponding compositions, methods of delivery and/or treatment |
| 08/09/2006 | EP1686967A2 Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
| 08/09/2006 | EP1455779B1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 08/09/2006 | EP1224168B1 Antifungal enediynes |
| 08/09/2006 | EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands |
| 08/09/2006 | CN1816552A Method for producing alkoxy-substituted phthalocyanins |
| 08/09/2006 | CN1816532A Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 08/09/2006 | CN1816522A Advanced route for the synthesis of CPLA2 inhibitors |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/08/2006 | US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 08/08/2006 | US7087757 Phenyl-substituted imidazopyridines |
| 08/08/2006 | US7087750 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087635 3-substituted oxindole β3 agonists |
| 08/08/2006 | US7087611 Reacting ziprasidone with hydrochloric acid in solvent; salt formation; drying |
| 08/08/2006 | US7087593 Psychological disorder treatments that increase the activity of cholinergic receptors |
| 08/08/2006 | US7087416 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET) |
| 08/03/2006 | WO2006081343A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 08/03/2006 | WO2006080574A1 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 08/03/2006 | WO2006080555A1 Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)-2-phthalimidomethylcyclopropane |
| 08/03/2006 | WO2006080524A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 08/03/2006 | WO2006065479A3 Substituted phenols as active agents inhibiting vegf production |
| 08/03/2006 | WO2006034391A3 Indole inhibitors of 15-lipoxygenase |
| 08/03/2006 | WO2006014916A3 Preparation of trandolapril |
| 08/03/2006 | WO2006014262A3 Indoles having anti-diabetic activity |
| 08/03/2006 | WO2005113011A3 Prodrugs of ion channel modulating compounds and uses thereof |